EIR KBI Biopharma Sep 2020

Viviana Matta FDA$595.00 - Available Now

FDA investigators audited the KBI Biopharma - Durham, NC, United States facility and issued inspectional observation (via FDA 483) on 29 Sep 2020.

Product details

  • Category:
  • Inspection end: 29 Sep 2020
  • Location: Durham, United States
  • FEI: 3004638264
Add To Cart